Aster DM Healthcare Gets Approval for Listing 18.6 Million Shares Issued on Preferential Basis

BENGALURU, June 6, 2025 — Aster DM Healthcare Ltd (NSE: ASTERDM | BSE: 540975) has received listing approvals from both BSE and NSE for 1,86,07,969 equity shares allotted on a preferential basis to non-promoters, BCP Asia II TopCo IV Pte. Ltd and Centella Mauritius Holdings Limited. The equity shares of Rs. 10/- each were issued at a premium of Rs. 446.33/.

Listing Details

The newly issued shares carry a face value of ₹10 each and were issued at a premium of ₹446.33 per share, translating to a total issue price of ₹456.33, bearing distinctive numbers ranging from 505227346 to 523835314 and have been allotted to non-promoter entities.

These shares were issued pursuant to earlier intimations made to the stock exchanges dated March 13, 2025, and April 16, 2025, under SEBI’s preferential allotment norms. The listing is in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.

Regulatory Approvals

• The BSE approval letter dated June 5, 2025, confirms compliance with SEBI (ICDR) Regulation 167. It mandates submission of the shareholding pattern in XBRL format if there is more than a 2% change in total paid-up capital. It also highlights the requirement to seek trading approval within seven working days of listing approval to avoid penalties..
• The NSE in-principle approval was issued on May 29, 2025, stating that shares would be admitted for trading upon confirmation of credit to beneficiary accounts by NSDL/CDSL.

Company Profile

Aster DM Healthcare Ltd, headquartered in Bengaluru, is a leading private healthcare service provider with operations across India and the GCC. The company operates a network of hospitals, clinics, and pharmacies and is known for its multi-specialty services under the “Aster,” “Medcare,” and “Access” brands.

This preferential allotment and subsequent listing approval is part of Aster’s broader strategy to attract strategic investments and enhance shareholder value while continuing to expand its presence in key healthcare markets.

Outlook

The preferential allotment of equity to shares to non-promoters elite and subsequent listing approval is part of the company’s broader strategy. It indicates that Aster plans to attract strategic investments and enhance shareholder value while expanding its presence in key healthcare markets.

REF: https://nsearchives.nseindia.com/corporate/ASTERDM2_06062025112456_SE_Intimation_signed.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations